JCM
WST icon

Jacobi Capital Management’s West Pharmaceutical WST Stock Holding History

Jacobi Capital Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$455K Sell
1,267
-34
-3% -$10.4K 0.02% 472
2026
Q1 		$326K Sell
1,301
-15
-1% -$3.73K 0.02% 521
2025
Q4 		$362K Sell
1,316
-29
-2% -$7.93K 0.02% 484
2025
Q3 		$353K Buy
1,345
+11
+0.8% +$2.67K 0.02% 469
2025
Q2 		$292K Buy
+1,334
New +$285K 0.02% 500
2021
Q4 		– Sell
-393
Closed -$167K – 1343
2021
Q3 		$167K Buy
393
+364
+1,255% +$153K 0.02% 430
2021
Q2 		$10K Buy
29
+7
+32% +$2.31K ﹤0.01% 1041
2021
Q1 		$6K Buy
+22
New +$6.3K ﹤0.01% 1092

Other funds holding WST

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $63.1B AUM 35.51% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $10.3B AUM 4.84% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Jacobi Capital Management's WST Position: Q2 2026 in Review

Jacobi Capital Management reduced its West Pharmaceutical (WST) stake by 2.6% in Q2 2026, selling an estimated $10.4K and leaving 1,267 shares worth $455K. The position accounts for 0.02% of the portfolio, ranked #472.

Jacobi Capital Management first reported a position in WST in Q1 2021 and has held it in 8 quarters since. 832 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Jacobi Capital Management held 1,267 shares of West Pharmaceutical worth $455K as of Q2 2026.
  • Jacobi Capital Management sold 34 West Pharmaceutical shares in Q2 2026, an estimated $10.4K.
  • West Pharmaceutical made up 0.02% of Jacobi Capital Management's portfolio in Q2 2026, its #472 holding.
  • Jacobi Capital Management first reported a position in West Pharmaceutical in Q1 2021 and has held it in 8 quarters since.
  • 832 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Jacobi Capital Management's 13F filing for Q2 2026, filed 31 Jul 2026.